Theracos, Inc. is a privately held pharmaceutical research and development company located in Sunnyvale, California. Theracos develops, acquires, and supports research programs in inflammation, metabolism, and depression through research activities throughout the world. Theracos establishes the clinical efficacy of its therapeutic candidates through multicenter international trials closely managed by a senior team of investigators.